%0 Journal Article
%T The relationship between preliminary efficacy and prognosis after first-line EGFR tyrosine kinase inhibitor (EGFR-TKI) treatment of advanced non-small cell lung cancer
%A Baohui Han
%A Dongfang Chen
%A Jiajun Teng
%A Liwen Xiong
%A Qing Chang
%A Rong Qiao
%A Runbo Zhong
%A Tianqing Chu
%A Yanwei Zhang
%J Archive of "Annals of Translational Medicine".
%D 2019
%R 10.21037/atm.2019.04.06
%K Non-small cell lung cancer (NSCLC)
%K EGFR tyrosine kinase inhibitor (EGFR-TKI)
%K first-line treatment
%K preliminary efficacy
%K progression-free survival (PFS)
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545314/